May/June 2007

Iridocorneal Endothelial Syndrome

Jason M. Yonker, MD, and Mark S. Juzych, MD, MHSA

Point/Counterpoint: Does Glaucoma Medications' BAK Content Make a Difference in Clinical Practice?

Yes, it matters.

Robert J. Noecker, MD, MBA

Bleb Leaks and Bleb-Related Infection

Understanding the relevant literature is essential to managing these conditions..

Jeffrey M. Zink, MD, and Francisco E. Fantes, MD

Induced Astigmatism After Trabeculectomy

Gianmarco Vizzeri, MD; Sameh Mosaed, MD; Felipe A. Medeiros, MD, PhD; and Robert N. Weinreb, MD

Elevated IOP After Cataract Surgery

Because patients who have already sustained glaucomatous damage are at greater risk of visual field loss from increased IOP, ophthalmologists must have an understanding of the various options for treating rises in pressure.

Parag A. Gokhale, MD, and Emory Patterson, MD

5 Questions With Wallace L. M. Alward, MD

Dr. Alward reflects on his days in Alaska, his early work in genetics, and the University of Iowa's appeal in glaucoma.

Wallace L. M. Alward, MD

No News Is Bad News

Richard A. Lewis, MD, Chief Medical Editor

Who Is a Good Candidate for SLT, and How Does This Modality Fit Into Your Treatment Algorithm?

Malik Y. Kahook, MD, and Robert J. Noecker, MD, MBA

Restoring Physiologic Outflow in Glaucoma

Bypassing the trabecular meshwork and restoring the natural flow of aqueous through the eye can help patients achieve lower IOPs and reduce their dependence on hypotensive drugs.

Julia T. Lewandowski, Senior Associate Editor